GLP1R and obesity due to melanocortin 4 receptor deficiency: Exenatide, which belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist family, has been used to treat diabetes and obesity chiefly owing to its prominent effects on insulin resistance, weight loss, and metabolic disorders [14, 15].